generatebiomedicines.com

# Generate:Biomedicines: Now we can\.

> Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of biology, machine learning, and biological engineering\.

Generated by Yoast SEO v28.1, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Careers](https://generatebiomedicines.com/careers/)
- [Biomedicines](https://generatebiomedicines.com/biomedicines/)
- [Generative Biology®](https://generatebiomedicines.com/generative-biology/)
- [Home](https://generatebiomedicines.com/)
- [The Generate Platform™](https://generatebiomedicines.com/platform/)

## Posts
- [Hello world\!](https://generatebiomedicines.com/hello-world/)

## Team Members
- [Rupert Vessey](https://generatebiomedicines.com/team-member/rupert-vessey/)
- [Nancy Simonian](https://generatebiomedicines.com/team-member/nancy-simonian/)
- [Paul Parker](https://generatebiomedicines.com/team-member/paul-parker/)
- [Jane Mendillo](https://generatebiomedicines.com/team-member/jane-mendillo/)
- [Marsha Fanucci](https://generatebiomedicines.com/team-member/marsha-fanucci/)

## Blog Posts
- [Designing Beyond Viral Evolution: Peer\-Reviewed First\-in\-Human Results for GB\-0669](https://generatebiomedicines.com/blog-posts/designing-beyond-viral-evolution-peer-reviewed-first-in-human-results-for-gb-0669/)
- [Introducing Generative Biology, Part I: Extracting the Hidden Principles of Biology with Machine Learning](https://generatebiomedicines.com/blog-posts/introducing-generative-biology-part-i/)
- [Generate:Biomedicines Wins Citeline 2021 Award for Most Innovative Start\-up Company](https://generatebiomedicines.com/blog-posts/generate-biomedicines-wins-citeline-2021-award-for-most-innovative-start-up-company/)
- [Introducing Generative Biology Part II: On the Brink of Transforming Drug Discovery](https://generatebiomedicines.com/blog-posts/introducing-generative-biology-part-ii/)
- [Four Years of Generate: The Leading Edge of a Revolution](https://generatebiomedicines.com/blog-posts/four-years-of-generate-the-leading-edge-of-a-revolution/)

## News Releases
- [Generate:Biomedicines Announces Multi\-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI](https://generatebiomedicines.com/news-releases/generatebiomedicines-announces-multi-target-collaboration-with-novartis/)
- [Generate:Biomedicines Provides Update on its Platform and Pipeline Powered by AI at the 43rd Annual J\.P\. Morgan Healthcare Conference](https://generatebiomedicines.com/news-releases/generatebiomedicines-provides-update-on-its-platform-and-pipeline/)
- [Generate:Biomedicines Expands Board of Directors with Appointment of Marsha Fanucci](https://generatebiomedicines.com/news-releases/generatebiomedicines-expands-board-of-directors-with-appointment-of-marsha-fanucci/)
- [Generate:Biomedicines Welcomes Laurie Lee, MD, as Chief Medical Officer for the Immunology \& Inflammation Portfolio](https://generatebiomedicines.com/news-releases/generate-welcomes-laurie-lee/)
- [Generate:Biomedicines to Present Phase 1 Results for AI\-Engineered GB\-0895 in Asthma at the European Respiratory Society International Congress](https://generatebiomedicines.com/news-releases/generatebiomedicines-to-present-phase-1-results/)

## Media Highlights
- [Q\&A: Generate Biomedicines CTO talks AI advancements](https://generatebiomedicines.com/media-highlights/qa-generate-biomedicines-cto-talks-ai-advancements/)
- [Can AI Drug Development Live Up to the Hype?](https://generatebiomedicines.com/media-highlights/can-ai-drug-development-live-up-to-the-hype/)
- [Drug Discovery News Webinar: How AI is Transforming Drug Discovery](https://generatebiomedicines.com/media-highlights/drug-discovery-news-webinar-how-ai-is-transforming-drug-discovery/)
- [Financial Times Best Legal Leaders Report – Sean Martin](https://generatebiomedicines.com/media-highlights/financial-times-best-legal-leaders-report-sean-martin/)
- [Drug Discovery \& Development 30 Biotech Startups Making Waves](https://generatebiomedicines.com/media-highlights/drug-discovery-development-30-biotech-startups-making-waves/)

## Publications
- [Randomized, Double\-Blind, Placebo\-Controlled First\-in\-Human Trial of a First\-in\-Class AI\-Designed Monoclonal Antibody \(GB\-0669\) Against the Conserved SARS\-CoV‑2 Spike S2 Stem Helix](https://generatebiomedicines.com/publications/randomized-double-blind-placebo-controlled-first-in-human-trial-of-a-first-in-class-ai-designed-monoclonal-antibody-gb-0669-against-the-conserved-sars-cov-2-spike-s2-stem-helix/)
- [Protein re\-surfacing of E\. coli L\-Asparaginase to evade pre\-existing anti\-drug antibodies and hypersensitivity responses](https://generatebiomedicines.com/publications/protein-re-surfacing-of-e-coli-l-asparaginase-to-evade-pre-existing-anti-drug-antibodies-and-hypersensitivity-responses-2/)
- [Illuminating Protein Space With a Programmable Generative Model](https://generatebiomedicines.com/publications/illuminating-protein-space-with-a-programmable-generative-model-2/)
- [IDWeek 2024: First\-in\-human study of a novel half life extended monoclonal antibody \(GB\-0669\) against SARS\-CoV\-2 and related sarbecoviruses](https://generatebiomedicines.com/publications/idweek-2024-ftih-presentation/)
- [IDWeek 2024: Machine learning\-guided generation of a potent combination of broadly neutralizing sarbecovirus antibodies with a high barrier to resistance](https://generatebiomedicines.com/publications/id-week-2024-preclinical/)

## Categories
- [Uncategorized](https://generatebiomedicines.com/category/uncategorized/)

## Optional
- [Sitemap index](https://generatebiomedicines.com/sitemap_index.xml)